Stock Scorecard
Stock Summary for Inotiv Inc (NOTV) - $5.38 as of 4/18/2024 7:26:46 PM EST
Total Score
9 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for NOTV
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for NOTV
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for NOTV
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 |
Bonus Criteria for NOTV
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for NOTV
Financial Details for NOTV
Company Overview |
|
|---|---|
| Ticker | NOTV |
| Company Name | Inotiv Inc |
| Country | USA |
| Description | Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. The company is headquartered in West Lafayette, Indiana. |
| Sector Name | TRADE & SERVICES |
| Industry Name | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
| Most Recent Quarter | 12/31/2023 |
| Next Earnings Date | 5/9/2024 |
Stock Price History |
|
| Last Day Price | 5.38 |
| Last Day Price Updated | 4/18/2024 7:26:46 PM EST |
| Last Day Volume | 319,739 |
| Average Daily Volume | 495,522 |
| 52-Week High | 11.42 |
| 52-Week Low | 1.61 |
| Last Price to 52 Week Low | 234.16% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 31.68 |
| Sector PE | 40.20 |
| 5-Year Average PE | -30.72 |
| Free Cash Flow Ratio | 6.33 |
| Industry Free Cash Flow Ratio | 44.53 |
| Sector Free Cash Flow Ratio | 84.46 |
| Current Ratio Most Recent Quarter | 1.74 |
| Total Cash Per Share | 0.85 |
| Book Value Per Share Most Recent Quarter | 9.86 |
| Price to Book Ratio | 0.60 |
| Industry Price to Book Ratio | 8.15 |
| Sector Price to Book Ratio | 8.77 |
| Price to Sales Ratio Twelve Trailing Months | 0.26 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.00 |
| Sector Price to Sales Ratio Twelve Trailing Months | 1.87 |
Share Statistics |
|
| Total Shares Outstanding | 25,790,700 |
| Market Capitalization | 138,753,966 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Dividend Aristocrat? | False |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.71% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 68.80% |
| Reported EPS 12 Trailing Months | -1.29 |
| Reported EPS Past Year | -0.60 |
| Reported EPS Prior Year | -1.02 |
| Net Income Twelve Trailing Months | -33,205,000 |
| Net Income Past Year | -105,140,000 |
| Net Income Prior Year | -337,018,000 |
| Quarterly Revenue Growth YOY | 10.40% |
| 5-Year Revenue Growth | 82.32% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 22,001,000 |
| Total Cash Past Year | 35,492,000 |
| Total Cash Prior Year | 18,515,000 |
| Net Cash Position Most Recent Quarter | -367,916,000 |
| Net Cash Position Past Year | -353,650,000 |
| Long Term Debt Past Year | 389,142,000 |
| Long Term Debt Prior Year | 350,655,000 |
| Total Debt Most Recent Quarter | 389,917,000 |
| Equity to Debt Ratio Past Year | 0.41 |
| Equity to Debt Ratio Most Recent Quarter | 0.39 |
| Total Stockholder Equity Past Year | 269,154,000 |
| Total Stockholder Equity Prior Year | 360,372,000 |
| Total Stockholder Equity Most Recent Quarter | 254,162,000 |
Options |
|
| Put/Call Ratio | 0.20 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.50 |
| 20-Day Bollinger Lower Band | 0.54 |
| 20-Day Bollinger Middle Band | 5.63 |
| 20-Day Bollinger Upper Band | 10.71 |
| Beta | 3.20 |
| RSI | 41.16 |
| 50-Day SMA | 4.79 |
| 200-Day SMA | 14.90 |
System |
|
| Modified | 4/18/2024 7:07:51 AM EST |